APIC Conference Education Library

Log-in / Create Account

Session Information

APIC 2009 Annual Conference

Click here to go to the previous page

The Changing Epidemiology of Clostridium difficile Infection

Track : 2008 Clostridium difficile Conference

Program Code: 010

SPEAKER :

Dale N. Gerding, MD, Associate Chief of Staff, Research & Development, Hines Veterans Affairs

Dr. Gerding is Associate Chief of Staff for Research and Development at the Hines Veterans Affairs Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. Prior to his present position Dr. Gerding was Chief of Medicine at VA Chicago, Lakeside Division, and Professor of Medicine at Northwestern University Feinberg School of Medicine. Prior to moving to Chicago he was Chief of Infectious Diseases at the Minneapolis VA Medical Center and Professor of Medicine and Laboratory Medicine/Pathology at the University of Minnesota Medical School. Dr. Gerding received his undergraduate degree in physics from St. John�s University in Collegeville, MN, attended graduate school in physics at UCLA in Los Angeles, California, and received his MD degree from the University of Minnesota Medical School. He was a medical intern at the Peter Bent Brigham Hospital in Boston and following two years at the National Institutes of Health completed his medical residency and infectious diseases fellowship at the University of Minnesota and Minneapolis VA Medical Center. He is board certified in Internal Medicine and Infectious Diseases.He is an infectious diseases specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America and past chair the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America and past Chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He is currently a member of the Board of Directors of IDSA. He is a fellow of the American College of Physicians and a member of the American Society for Microbiology. His research interests include the epidemiology and prevention of Clostridium difficile disease, antimicrobial resistance, and antimicrobial distribution and kinetics. He has been a Merit Review funded research investigator in the VA for over 30 years and is the author of over 300 peer-reviewed journal articles, book chapters, reviews and letters. He holds patents for the use of non-toxigenic C. difficile for the prevention and treatment of this disease. He is a member of the editorial boards of Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, and Infection Control and Hospital Epidemiology, and is an ad hoc reviewer for numerous other medical journals.